about
Clinical prognostic factors in adults with astrocytoma: Historic cohort.Brain angiometastasis from a non-seminomatous germ cell tumor: A case report.Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study.Role of epigenetics and oxidative stress in gliomagenesis.Comorbidities, Clinical Features, and Prognostic Implications of Cancer Patients with Cerebrovascular Disease.Central Nervous System Metastases in Patients With Cervical Carcinoma.[First Mexican consensus on recommendations of the multidisciplinary care of patients with glioblastoma multiforme (GBM): Mexican Interdisciplinary Group on Neuro-Oncology Research (GIMINO)].Cervical Intramedullary Schwannoma: Case Report and Review of the Literature.The possibility of cancer immune editing in gliomas. A critical review.Myasthenia gravis as a prognostic marker in patients with thymoma.Platelet count is associated with outcome in cancer patients with strokeAngiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytomaGelatin Paste as an alternative cost-effective hemostatic agent in cranial surgery: Doing More with LessThe Comparative Treatment of Intraventricular Chemotherapy by Ommaya Reservoir vs. Lumbar Puncture in Patients With Leptomeningeal CarcinomatosisQuality of Life in Brain Cancer: Clinical Validation of the Mexican-Spanish Version of the EORTC QLQ-BN20 QuestionnaireLactate dehydrogenase as a prognostic marker in neoplastic meningitisRadiotherapy induced cavernomas in adult cancer patientsNeurologic manifestations of elderly patients with cancerChoice of antiepileptic drugs affects the outcome in cancer patients with seizuresClinical manifestations and location of brain metastases as prognostic markersFactors associated with long-term survival in central nervous system metastases[Primary Tumors of the Central Nervous System. Clinical Experience at a Third Level Center]Diagnosis of brain metastases in breast cancer patients resulting from neurological symptomsRole of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain MetastasesChemotherapy-induced posterior reversible encephalopathy syndrome: Three case reportsTumor microenvironment differences between primary tumor and brain metastasesAssociation of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patientsVertigo in patients with cancer: Red flag symptomsClinical presentation, risk factors and outcome of central nervous system metastasis vs stroke in cancer patientsIdentification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptomsLandscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma
P50
Q40743051-DD44E377-7B27-42D2-A27C-EEA7E5F3DD01Q47136436-21F688C5-1528-49E6-9312-341700F58EC3Q47138708-2D520892-C3D2-4257-8682-E3D9C6F9FE52Q47214687-E25F7A64-01CF-4341-972A-E763CFDFBE45Q47581335-35044329-D078-42E8-81C6-EB5CEFDD3032Q47903180-168C13F0-767D-416F-A640-71C1395AE995Q53462787-DA76895E-BC8F-4B5F-939E-40610112AFBBQ55129519-39ED0001-4EA3-4206-B02F-8F65F7B285D1Q55162070-C45F7E5C-3B64-4850-A4DF-FB713538EBBEQ55615736-A206EECB-B18F-444B-B271-AB4F6B855284Q57168620-513AFB10-22A0-4783-A25F-1FA93577890FQ58085056-E3F7C2C4-11CB-4C7C-B75D-B7EE56261099Q58591164-824537EB-C697-4A78-8BB9-445FF1DA3FF7Q59791872-08A99790-34A4-46D3-8981-0A3941F38F30Q61806031-5D33170A-EB31-4C00-A391-AF94858CDE43Q87887051-C864E82B-1947-4BB5-A95A-36E13E5C9A32Q88135578-B9B1EE1D-692B-4DDE-B58E-7E8923C69825Q88499326-9B0C183A-89B4-4847-9ACD-826F8286E193Q88990486-1CB89D40-13A7-407F-BAB5-DAD00D6B1244Q90004057-94283BA7-DDD1-43ED-8035-A8C04013A37DQ90019755-700837AA-518F-4256-96B0-8C420D1D97E8Q90689489-B6A06400-3232-4637-95DB-BAD968B9FECFQ90818202-4AD2F99C-2E6F-498A-BCCA-6B3C8041A900Q91465979-1505D2D9-0E76-4B55-A2E7-95B8C0937276Q91979943-D690614F-C9D1-4A84-B2EB-17B93A7304ACQ92405024-6425558A-4909-424B-8EB1-0FA709084851Q92567469-5EE52BA4-B051-497E-9617-9AD8898693A8Q92600593-20C012C1-8975-4A41-A999-A037B2EED894Q93347074-FF40CCF2-7472-4FE1-B327-4FD83222B336Q95843521-0B688274-4867-4A94-BD49-6B4D26E19544Q96341075-06497C64-FCEF-49D5-A498-3C3E3C31613F
P50
description
researcher
@en
wetenschapper
@nl
name
Bernardo Cacho-Díaz
@en
Bernardo Cacho-Díaz
@nl
type
label
Bernardo Cacho-Díaz
@en
Bernardo Cacho-Díaz
@nl
prefLabel
Bernardo Cacho-Díaz
@en
Bernardo Cacho-Díaz
@nl
P31
P496
0000-0001-9289-5312